We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

ATMPs

Track:
Can Regulators and HTA Bodies Create Synergies for Patient Access?

Day & Time:
April 19, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S0104

Room Number:
Singapore

Type:
Session

Title:
ATMPs

Chair(s):
Ana Hidalgo-Simon, DrMed
Head of Section Risk Management
European Medicines Agency, European Union, United Kingdom

Description:
ATMPs

Presentation(s) & Speaker(s):
Parallel Scientific Advice ATMPs with HTAs
Anja Schiel, PhD
Senior Adviser / Statistician, Unit for HTA and Reimbursement
Norwegian Medicines Agency, Norway

ATMPs Access to Patients and the HTA Perspective
Rimma Berenstein, PhD
Scientific Advisor
Gemeinsamer Bundesausschuss (Federal Joint Committee), Germany

Panel Discussion
Deborah Morrison
Senior Scientific Adviser
National Institute for Health and Care Excellence (NICE), United Kingdom

Panel Discussion
Shuvayu Sankar Sen, PhD, MS
Executive Director, CORE, Merck
Merck Research Laboratories, United States